Literature DB >> 27076632

The ABCs of STIs: An Update on Sexually Transmitted Infections.

Melanie L Yarbrough1, Carey-Ann D Burnham2.   

Abstract

BACKGROUND: Sexually transmitted infections (STIs) are spread primarily through sexual contact and are a major cause of morbidity and mortality worldwide. Once identified, some STIs can be cured following appropriate therapy; for others, suppressive regimens and approaches to prevent ongoing transmission are important. The incidence of many common STIs is increasing in the US as well as worldwide, and hundreds of millions of people are currently infected. Laboratory testing plays a major role in the diagnosis and treatment of STIs, and clinical laboratorians should be familiar with the current guidelines and methods for testing. CONTENT: Accurate and sensitive methods to diagnose STIs are essential to direct appropriate antimicrobial therapy and interrupt the cycle of disease transmission. This review summarizes laboratory testing for common bacterial, viral, and parasitic causes of STIs. Disease manifestations reviewed include cervicitis and urethritis, genital ulcerative disease, human immunodeficiency virus, viral hepatitis, human papilloma virus, and vaginitis. Recent advancements in the recognition and management of STIs, including updates to diagnostic algorithms, advances in testing methods, and emerging challenges with antimicrobial resistance, are summarized.
SUMMARY: Diagnostic methods and therapeutic guidelines for STIs are rapidly evolving. In combination with changing epidemiology, the development of novel therapeutics, and advancements in diagnostic methods, this has resulted in changing practices in laboratory testing and, subsequently, management of disease. Molecular methods have facilitated personalized therapy and follow-up regimens targeted for individual types or strains of some STIs.
© 2016 American Association for Clinical Chemistry.

Entities:  

Mesh:

Year:  2016        PMID: 27076632     DOI: 10.1373/clinchem.2015.240234

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Clinical Performance of the BioPlex 2200 Syphilis Total & RPR Assay at a Tertiary Medical Center with a High Rate of Syphilis.

Authors:  Merih T Tesfazghi; Neil W Anderson; Ann M Gronowski; Melanie L Yarbrough
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

2.  Sexual behaviors at home and abroad: an online survey of Canadian young adult travelers.

Authors:  Emmanuelle Gareau; Karen P Phillips
Journal:  BMC Public Health       Date:  2022-05-13       Impact factor: 4.135

3.  The Human Penis Is a Genuine Immunological Effector Site.

Authors:  Alexis Sennepin; Fernando Real; Marine Duvivier; Yonatan Ganor; Sonia Henry; Diane Damotte; Marc Revol; Sonia Cristofari; Morgane Bomsel
Journal:  Front Immunol       Date:  2017-12-14       Impact factor: 7.561

Review 4.  Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections.

Authors:  Giorgia Caruso; Anna Giammanco; Roberta Virruso; Teresa Fasciana
Journal:  Int J Environ Res Public Health       Date:  2021-01-25       Impact factor: 3.390

5.  Key informant perspectives on sexual health services for travelling young adults: a qualitative study.

Authors:  Emmanuelle Gareau; Karen P Phillips
Journal:  BMC Health Serv Res       Date:  2022-02-04       Impact factor: 2.655

Review 6.  Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers.

Authors:  Maryam Soheili; Hossein Keyvani; Marzieh Soheili; Sherko Nasseri
Journal:  Med J Islam Repub Iran       Date:  2021-05-22

7.  Proximity to Screening Site, Rurality, and Neighborhood Disadvantage: Treatment Status among Individuals with Sexually Transmitted Infections in Yakima County, Washington.

Authors:  Solmaz Amiri; Christine D Pham; Ofer Amram; Karl C Alcover; Oladunni Oluwoye; Lilian Bravo; Melissa Sixberry; Michael G McDonell; John M Roll; Andre Fresco
Journal:  Int J Environ Res Public Health       Date:  2020-04-14       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.